iGluco receives an R&D grant from the CDTI.

Written by Víctor Rosa


Today we are on fire! And we couldn’t have a better start to the year. CDTIoficial Centro para el Desarrollo Tecnológico Industrial para el Desarrollo Tecnológico Industrial del Ministerio de Ciencia e Innovación de España has granted us an important subsidy within Proyectos I+D Transferencia Cervera.

Thanks to this grant, we are going to do everything possible to make the non-invasive blood glucose #measuring edevice a reality. Reliable, easy to use and within everyone’s reach.

At iGluco Tech we couldn’t be happier, knowing that thanks to our device the lives of so many people with diabeteswill improve. Get ready for 2022, iGluco is on its way!

o Project objectives: To bring to the market its smart, needle-free glucose measurement device that improves the quality of life of diabetics.
o It is located at Avda. de República Argentina 25 Planta 8 41011 Seville.
o The project starts on December 3, 2020 and ends on February 28, 2022.
o Co-financing CDTI and FEDER : The granting of a partially reimbursable aid with interest of up to 245,427.86€, which represents a percentage of 85.00% of the total budget accepted by this centre, which amounts to 288. 739.00, the aid is broken down into a non-refundable part amounting to 33.00% calculated on the financial coverage of the aid, coverage which for the purposes of this calculation of the non-refundable tranche has a maximum of 75.00% of the total budget accepted, and a refundable part comprising the rest of the aid to which interest of 0.00% per annum will be applied.

You May Also Like…

No Results Found

The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.


Pin It on Pinterest